Blackmores' bitter pill

Blackmores is an Australian healthcare success story. But potential industry changes and a high price mean investors should beware.

For investors interested in Blackmores, the plan to ‘Buy low, sell high’ is long forgotten. The strategy that replaced it – ‘Buy high, sell higher’ – has also been thrown out. Now, fans of the supplement maker – whose shares have risen fourfold over the past 12 months – just scream ‘Get me in!’


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles